lung function

April 16, 2019April 16, 2019

Early Antibiotic Treatment Better to Eradicate New MRSA Infections in CF Patients, Study Suggests

cystic fibrosis, News

Using antibiotics to fully eliminate new methicillin-resistant Staphylococcus aureus (MRSA) airway infections appears more effective than waiting for the infection to pass naturally in patients with cystic fibrosis (CF), a ... Read more

April 8, 2019

Choline Supplementation Improves Lung Function, Liver Health in CF Patients, Study Shows

cystic fibrosis, News

Choline supplementation improves lung function and liver health in people with cystic fibrosis (CF), and should be considered as a complementary treatment to current standard care therapies, a study ... Read more

April 1, 2019April 1, 2019

Canadian CF Patients Have Better Lung Function, But More Abnormal Glucose Metabolism Than French Patients, Study Reports

cystic fibrosis, News

Canadian patients with cystic fibrosis (CF) have better respiratory function and higher body mass index (BMI) than French patients, although they have higher blood glucose levels and a greater ... Read more

March 27, 2019March 27, 2019

Triple Combo of Proteostasis’ CFTR Modulators May Benefit CF Patients, Phase 1 Trial Shows

cystic fibrosis, News

Treatment with Proteostasis Therapeutics’ triple combo therapy regimen may significantly improve the lung function of patients with cystic fibrosis (CF), results from a Phase 1 clinical trial suggest. The ... Read more

March 26, 2019March 26, 2019

Asthma Medicine Xolair Successfully Treats Lung Allergy Due to Fungal Infection in 3 CF Patients, Case Report Shows

cystic fibrosis, News

Xolair (omalizumab), a medicine used for allergic asthma and chronic hives, is effective for treating lung allergic reactions caused by fungi in patients with cystic fibrosis (CF), a case ... Read more

March 14, 2019April 18, 2019

Symdeko Approved in Australia for CF Patients Age 12 or Older With Certain Gene Mutations

News

Cystic fibrosis (CF) patients in Australia age 12 and older, who have two copies of the F508del mutation in the CFTR gene (a copy inherited from each parent), now can be treated with Vertex Pharmaceuticals’ Symdeko (tezacaftor/ivacaftor and ... Read more

March 8, 2019March 26, 2019

Positive Data from VX-445 Triple Combo Regimen Prompt Vertex to Seek Regulatory Approval

News

Vertex Pharmaceuticals is planning to request regulatory approval from the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) during the third and fourth quarters of 2019, ... Read more

March 6, 2019March 19, 2019

Translate Bio Advancing MRT5005 Through Ongoing Phase 1/2 Trial in CF Patients

cystic fibrosis, News

An ongoing Phase 1/2 clinical trial exploring Translate Bio’s investigational therapy MRT5005 will start testing multiple ascending doses (MAD) in patients with cystic fibrosis (CF). This follows an assessment ... Read more

February 27, 2019March 13, 2019

Low-dose Antibiotics Preserve Airway Bacterial Diversity, but at a Cost, Study Finds

cystic fibrosis

Using lower, or suboptimal, doses of antibiotics to treat lung infections in children and young adults with cystic fibrosis (CF) leads to fewer changes in airway bacterial diversity compared ... Read more

February 13, 2019February 25, 2019

An Open Letter to the ‘How Are You Feeling?’ Folks

Columns, Modern CF Mama - a Column by Janeil Whitworth

Dear “How are you feeling?” folks, Those of us with a chronic illness hear repeatedly — and secretly dread — questions such as the following: “How are you feeling? ... Read more

Pin It on Pinterest